Evidence map›Paper›PMID 26935748›Full record

Trial reportJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia2016

Thin-film optical notch filter spectacle coatings for the treatment of migraine and photophobia.

Ryan N Hoggan, Amith Subhash, Steve Blair, Kathleen B Digre, Susan K Baggaley, Jamison Gordon, K C Brennan, Judith E A Warner, Alison V Crum, Bradley J Katz

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Blue Light-Ocular and Systemic Damaging Effects: A Narrative Review.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Future directions in neuro-optometry.Concussion (London, England) · 2020
    Article
  18. Visual and non-visual properties of filters manipulating short-wavelength light.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2019
    Article
  19. Article
  20. Current understanding of photophobia, visual networks and headaches.Cephalalgia : an international journal of headache · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ryan N HogganDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA.
Amith SubhashDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA.
Steve BlairDepartment of Electrical and Computer Engineering, University of Utah, Salt Lake City, UT, USA.
Kathleen B DigreDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA; Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Susan K BaggaleyDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.
Jamison GordonDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA.
K C BrennanDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.
Judith E A WarnerDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA; Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Alison V CrumDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA.
Bradley J KatzDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT 84132, USA; Department of Neurology, University of Utah, Salt Lake City, UT, USA. Electronic address: Bradley.Katz@hsc.utah.edu.
University of Utah · US

Funding

UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCAUL1RR025764 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$19.4M
University of Utah Center for Clinical and Translational Science-UL1UL1TR000105 · NCATS · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2012 to 2013
$5.1M
Short-Term Training: Students in Health Professional SchoolsT35HL007744 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS, TRISTANI-FIROUZI, MARTIN · 1993 to 2025
$3.1M
Sensory plasticity in migraineR01NS085413 · NINDS · UNIVERSITY OF UTAH · PI BRENNAN, KEVIN CHRISTOPHER · 2013 to 2017
$1.7M
NCATS NIH HHS UL1 TR000105NCRR NIH HHS UL1 RR025764NHLBI NIH HHS T35 HL007744NINDS NIH HHS R01 NS085413
6 · The paper itself

Abstract

Previous evidence suggests optical treatments hold promise for treating migraine and photophobia. We designed an optical notch filter, centered at 480nm to reduce direct stimulation of intrinsically photosensitive retinal ganglion cells. We used thin-film technology to integrate the filter into spectacle lenses. Our objective was to determine if an optical notch filter, designed to attenuate activity of intrinsically photosensitive retinal ganglion cells, could reduce headache impact in chronic migraine subjects. For this randomized, double-masked study, our primary endpoint was the Headache Impact Test (HIT-6; GlaxoSmithKline, Brentford, Middlesex, UK). We developed two filters: the therapeutic filter blocked visible light at 480nm; a 620nm filter was designed as a sham. Participants were asked to wear lenses with one of the filters for 2weeks; after 2weeks when no lenses were worn, they wore lenses with the other filter for 2weeks. Of 48 subjects, 37 completed the study. Wearing either the 480 or 620nm lenses resulted in clinically and statistically significant HIT-6 reductions. However, there was no significant difference when comparing overall effect of the 480 and 620nm lenses. Although the 620nm filter was designed as a sham intervention, research published following the trial indicated that melanopsin, the photopigment in intrinsically photosensitive retinal ganglion cells, is bi-stable. This molecular property may explain the unexpected efficacy of the 620nm filter. These preliminary findings indicate that lenses outfitted with a thin-film optical notch filter may be useful in treating chronic migraine.

Indexed as

Equipment DesignEyeglassesAdultAgedDouble-Blind MethodFemaleHumansLightMaleMiddle AgedMigraine DisordersPhotophobiaRetinal Ganglion CellsTreatment OutcomeYoung AdultIntrinsically photosensitive retinal ganglion cellsLight sensitivityMelanopsinMigrainePhotophobiaThin-film

Identifiers

PMID26935748
PMCPMC5510464
OpenAlexW2277475520

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.